Cart
sales@molnova.com
MZ-242
CAS No. 1862238-01-4
MZ-242( MZ242 | MZ242 )
Catalog No. M12877 CAS No. 1862238-01-4
A novel potent, selective Sirt2 inhibitor with IC50 of 0.118 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 963 | Get Quote |
|
| 50MG | 1962 | Get Quote |
|
| 100MG | 2520 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMZ-242
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel potent, selective Sirt2 inhibitor with IC50 of 0.118 uM.
-
DescriptionA novel potent, selective Sirt2 inhibitor with IC50 of 0.118 uM; displays no inhibitory activity against Sirt1 and Sirt 3 (IC50>100 uM).
-
In Vitro——
-
In Vivo——
-
SynonymsMZ242 | MZ242
-
PathwayChromatin/Epigenetic
-
TargetSirtuin
-
RecptorSirtuin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1862238-01-4
-
Formula Weight525.646
-
Molecular FormulaC24H27N7O3S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=NC=C(CC2=CC=CC(OCC3=CN(CCOC)N=N3)=C2)S1)CSC4=NC(C)=CC(C)=N4
-
Chemical Name2-((4,6-dimethylpyrimidin-2-yl)thio)-N-(5-(3-((1-(2-methoxyethyl)-1H-1,2,3-triazol-4-yl)methoxy)benzyl)thiazol-2-yl)acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Szabó A, et al. Sci Rep. 2017 Dec 6;7(1):17070.
2. Schiedel M, et al. Angew Chem Int Ed Engl. 2016 Feb 5;55(6):2252-6.
molnova catalog
related products
-
ADTL-SA1215
ADTL-SA1215 is a selective SIRT3 activator with SIRT3 deacetylase activity that inhibits the proliferation and migration of human breast cancer MDA-MB-231 cells through the SIRT3-driven autophagy/mitochondrial autophagy signaling pathway, and can be used in the study of triple negative breast cancer.
-
MC3482 B
MC3482 is a specific inhibitor of sirtuin5 (SIRT5).
-
EX 527 (Selisistat)
EX 527 is a potent and selective SIRT1 inhibitor with IC50 of 38 nM, exhibits >200-fold selectivity against SIRT2 and SIRT3.
